U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

The Centres for Medicare and Medicaid Services (CMS) said late on Friday that it would not cover anti-obesity medicines (AOMs) like Novo Nordisk's Wegovy (semaglutide) and Eli Lilly's Zepbound ...

Medicare’s block on obesity medication coverage can be traced back to a ... and Eli Lilly’s Zepbound (tirzepatide), which generally have to be paid for out-of-pocket as many private health ...

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

Learn how and where to inject Zepbound and where to get additional help. Plus, get tips for injecting the drug at home and ...

Kennedy Jr. to keep a proposed Biden-era rule that would have allowed Medicare and Medicaid to cover drugs used to treat obesity after the Trump administration decided not to finalize it.

A pair of studies show that Zepbound can help adults with obesity and overweight achieve sustained and meaningful weight loss ...

But when I stopped asking for them after starting Zepbound, the kids stopped asking too. So we’re all doing a lot less late-night snacking. We’re self-employed and my insurance didn’t cover ...

AARP is a well-known company that offers supplemental health insurance for senior citizens looking to fill gaps in their Medicare coverage. The company offers eight Medicare plans through United ...

Medicare is available to all U.S. adults ages 65 and older, regardless of income. However, your income can affect how much you pay for coverage. If you make a higher income, you’ll pay more for ...

Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift Monday, after a potential competitor decided to cancel development of its GLP-1 obesity drug. “We continue ...